At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 53 enrolled
Drug / intervention
Calcium Carbonate +1 moredrug
Likely dose
Calcium Carbonate 600mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Open-label, Parallel Groups-controlled Clinical Trial to Evaluate the Effect of Calcium Plus Vitamin D Supplementation on Weight Management in Overweight and Obese Very-low Calcium Consumers
In Brief
A Phase 4 clinical trial evaluating Calcium Carbonate and Energy restriction for Obesity and Overweight. Completed, enrolled 53 participants across 1 site.
Detailed Summary
The purpose of the study is to determine whether calcium plus vitamin D supplementation is conducive to weight and fat loss during energy restriction in very-low calcium consumers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Overweight
CountriesChina
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2011
First PostedOct 2011
Primary CompletionJan 2012
Study CompletionFeb 2012
TodayJul 2026
First PostedOct 6, 2011
Enrollment StartApr 1, 2011
Primary CompletionJan 1, 2012
Study CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.7 years ago
Interventions
Calcium Carbonatedrug
tablet, 600mg elemental calcium and 125IU vitamin D, once daily, for 12 weeks
Energy restrictionbehavioral
A balanced diet contains 500kcal of caloric deficit based on daily energy expenditure.